TNFSF14 Antikörper (AA 90-103)
-
- Target Alle TNFSF14 Antikörper anzeigen
- TNFSF14 (Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14))
-
Bindungsspezifität
- AA 90-103
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TNFSF14 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Spezifität
- Human TNFSF14 / LIGHT. This antibody is expected to recognize both reported isoforms (NP_003798.2, NP_742011.1).
- Homologie
- Percent identity by BLAST analysis: Human, Gorilla (100%) Gibbon (93%) Marmoset, Panda, Horse (86%).
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide C-HEVNPAAHLTGANS from an internal region of human TNFSF14 / LIGHT (NP_003798.2, NP_742011.1). Percent identity by BLAST analysis: Human, Gorilla (100%), Gibbon (93%), Marmoset, Panda, Horse (86%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product TNFSF14 Primärantikörper
-
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (AA 62-240) antibody
TNFSF14 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (AA 61-170) antibodyTNFSF14 Reaktivität: Human WB, ELISA, IP, IHC (p) Wirt: Maus Monoclonal 4E3 unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (AA 141-240) antibodyTNFSF14 Reaktivität: Maus, Ratte WB, FACS, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (AA 51-239) antibodyTNFSF14 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (AA 62-240) antibodyTNFSF14 Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal C1 unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (AA 1-239) antibodyTNFSF14 Reaktivität: Human WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (Internal Region) antibodyVerified TNFSF14 Reaktivität: Human WB, ELISA, IF Wirt: Ziege Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (AA 58-239) antibodyTNFSF14 Reaktivität: Ratte WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (AA 1-204) antibodyTNFSF14 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
-
- Applikationshinweise
-
Approved: Peptide-ELISA, WB (1 - 3 μg/mL)
Usage: Western Blot: Approx 22kD band observed in Human Brain (Cerebellum and Frontal Cortex) lysates (calculated MW of 22.4kD according to NP_742011.1). Recommended concentration: 1-3 μg/mL.
Not recommended for: IHC-P - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Tris-buffered saline, pH 7.3, 0.5 % BSA, 0.02 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze-thaw cycles.
-
- Target
- TNFSF14 (Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14))
- Andere Bezeichnung
- TNFSF14 / LIGHT (TNFSF14 Produkte)
- Synonyme
- TNFSF14 antikoerper, CD258 antikoerper, HVEML antikoerper, LIGHT antikoerper, LTg antikoerper, TR2 antikoerper, HVEM-L antikoerper, Ly113 antikoerper, TNF superfamily member 14 antikoerper, tumor necrosis factor (ligand) superfamily, member 14 antikoerper, TNFSF14 antikoerper, Tnfsf14 antikoerper
- Hintergrund
-
Name/Gene ID: TNFSF14
Family: TNF
Synonyms: TNFSF14, CD258 antigen, CD258, Delta transmembrane LIGHT, Herpesvirus entry mediator A, HVEM-L, TR2, HVEML, LIGHT, LTg - Gen-ID
- 8740
- NCBI Accession
- NP_003798, NP_742011
- UniProt
- O43557
- Pathways
- Cancer Immune Checkpoints
-
